MNPR insider trades & Congress trades
Monopar Therapeutics: public insider filings and Congress disclosures, in one place.
Bourse has recorded 25 open-market insider transactions in Monopar Therapeutics (MNPR) (0 purchases with code P and 25 sales with code S), the most recent on November 4, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 25 sales by 5 ($4.53M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 1,295 | $70.75 | $92K | – |
| Nov 4, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 996 | $71.35 | $71K | – |
| Nov 4, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 600 | $72.21 | $43K | – |
| Nov 2, 2026 | Anderson Raymond | – | Sell | 840 | $66.16 | $56K | – |
| Nov 2, 2026 | Anderson Raymond | – | Sell | 600 | $67.06 | $40K | – |
| Nov 2, 2026 | Anderson Raymond | – | Sell | 200 | $68.68 | $14K | – |
| Nov 2, 2026 | Anderson Raymond | – | Sell | 1,502 | $70.04 | $105K | – |
| Nov 2, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 1,199 | $70.10 | $84K | – |
| Oct 1, 2026 | Starr Christopher M | – | Sell | 4,631 | $78.09 | $362K | – |
| Oct 1, 2026 | Starr Christopher M | – | Sell | 2,970 | $78.82 | $234K | – |
| Oct 1, 2026 | Starr Christopher M | – | Sell | 799 | $79.67 | $64K | – |
| Sep 24, 2026 | Robinson Chandler | Chief Executive Officer | Sell | 10,450 | $87.15 | $911K | −0.1% |
| Sep 24, 2026 | Robinson Chandler | Chief Executive Officer | Sell | 9,638 | $87.96 | $848K | −0.1% |
| Sep 24, 2026 | Robinson Chandler | Chief Executive Officer | Sell | 8,368 | $88.97 | $745K | −0.1% |
| Sep 24, 2026 | Robinson Chandler | Chief Executive Officer | Sell | 600 | $89.79 | $54K | −0.1% |
| Aug 26, 2026 | Rioux Patrice | – | Sell | 1 | $111.26 | $111 | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 485 | $108.83 | $53K | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 615 | $109.56 | $67K | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 700 | $110.65 | $77K | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 1,098 | $111.84 | $123K | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 602 | $112.93 | $68K | −0.3% |
| Aug 26, 2026 | Tsuchimoto Kim R | Chief Financial Officer | Sell | 590 | $113.84 | $67K | −0.3% |
| Aug 25, 2026 | Anderson Raymond | – | Sell | 694 | $110.04 | $76K | −0.3% |
| Aug 25, 2026 | Anderson Raymond | – | Sell | 646 | $111.07 | $72K | −0.3% |
| Aug 25, 2026 | Anderson Raymond | – | Sell | 1,802 | $113.05 | $204K | −0.3% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.